Omeros | OMER - Ebitda

Stock Price
11.51
Daily Change
-0.08 -0.69%
Monthly
2.49%
Yearly
53.98%
Q1 Forecast
11.68

Omeros reported $-47.96M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Adma Biologics USD 58.74M 14.75M Sep/2025
Alnylam Pharmaceuticals USD 145.22M 236.56M Dec/2025
BioMarin Pharmaceutical USD -24.17M 18.91M Dec/2025
Cytokinetics USD -277.18M 169.36M Sep/2025
Gilead Sciences USD 4.03B 628M Sep/2025
Heron Therapeutics USD -3.88M 5.63M Sep/2024
Immunic USD -22.78M 753K Jun/2024
Insmed USD -314.19M 31.48M Dec/2025
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
MacroGenics USD 21.95M 55.39M Sep/2025
Omeros USD -47.96M 7.39M Sep/2023
Pacira USD 38.71M 10.65M Dec/2025
Pfizer USD 6.08B 351M Sep/2025
Sarepta Therapeutics USD -168.03M 294.45M Sep/2025
United Therapeutics USD 379.5M 83.4M Dec/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025
Xoma USD 2.52M 7.98M Jun/2024